Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Bladder (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 2.3 (2.3, 2.4) N/A 9,202 12.4
Maine 6 3.5 (3.1, 3.9) 1 (1, 6) 73 13.2
New Hampshire 6 3.2 (2.9, 3.6) 2 (1, 12) 62 12.4
Pennsylvania 6 2.9 (2.8, 3.0) 3 (2, 11) 523 13.3
West Virginia 6 2.9 (2.6, 3.2) 4 (1, 23) 79 13.8
Idaho 3 2.8 (2.5, 3.2) 5 (1, 29) 60 13.6
Wyoming 6 2.8 (2.2, 3.4) 6 (1, 44) 20 13.5
Vermont 6 2.8 (2.3, 3.3) 7 (1, 44) 25 12.0
Ohio 6 2.7 (2.6, 2.9) 8 (4, 19) 418 12.7
Alaska 6 2.7 (2.2, 3.4) 9 (1, 46) 19 14.8
Illinois 3 2.7 (2.6, 2.8) 10 (5, 20) 418 13.7
Wisconsin 6 2.7 (2.5, 2.8) 11 (4, 25) 203 12.3
Kentucky 3 2.6 (2.5, 2.8) 12 (4, 28) 150 12.5
North Dakota 6 2.6 (2.2, 3.2) 13 (1, 45) 24 13.4
Massachusetts 3 2.6 (2.5, 2.8) 14 (5, 26) 231 12.3
South Dakota 6 2.6 (2.2, 3.1) 15 (1, 44) 29 13.0
Michigan 6 2.6 (2.5, 2.7) 16 (6, 25) 347 12.9
Rhode Island 6 2.6 (2.2, 3.0) 17 (2, 42) 37 10.7
Montana 6 2.6 (2.2, 3.0) 18 (2, 44) 37 11.2
Iowa 3 2.6 (2.4, 2.8) 19 (4, 35) 107 12.0
Connecticut 3 2.5 (2.3, 2.7) 20 (6, 36) 121 11.0
Missouri 6 2.5 (2.4, 2.7) 21 (8, 34) 200 13.3
Oregon 6 2.5 (2.3, 2.7) 22 (7, 36) 139 12.8
Minnesota 6 2.5 (2.3, 2.7) 23 (8, 36) 169 11.7
District of Columbia 6 2.5 (1.9, 3.0) 24 (2, 49) 17 18.1
Washington 5 2.4 (2.3, 2.6) 25 (11, 37) 216 12.1
Tennessee 6 2.4 (2.2, 2.5) 26 (13, 40) 201 12.0
New Jersey 3 2.4 (2.2, 2.5) 27 (17, 39) 268 10.8
Florida 6 2.3 (2.3, 2.4) 28 (20, 37) 752 12.5
Kansas 6 2.3 (2.1, 2.6) 29 (10, 44) 83 11.1
Virginia 6 2.3 (2.2, 2.5) 30 (17, 40) 238 13.9
New York 3 2.3 (2.2, 2.4) 31 (20, 38) 581 10.8
North Carolina 6 2.3 (2.2, 2.4) 32 (18, 40) 301 12.3
Maryland 6 2.3 (2.1, 2.4) 33 (18, 42) 167 13.9
Oklahoma 6 2.3 (2.1, 2.5) 34 (15, 44) 109 12.5
Georgia 3 2.2 (2.1, 2.3) 35 (23, 43) 253 12.5
Louisiana 3 2.2 (2.0, 2.4) 36 (20, 45) 124 12.3
Arkansas 6 2.2 (2.0, 2.4) 37 (19, 46) 85 11.3
Nebraska 6 2.2 (1.9, 2.5) 38 (15, 47) 51 11.2
Delaware 6 2.2 (1.8, 2.6) 39 (7, 49) 30 9.8
South Carolina 6 2.2 (2.0, 2.3) 40 (22, 45) 145 12.9
Mississippi 6 2.1 (1.9, 2.3) 41 (23, 48) 75 12.3
California 3 2.1 (2.0, 2.1) 42 (37, 46) 905 13.1
Colorado 6 2.0 (1.9, 2.2) 43 (33, 48) 127 11.6
Alabama 6 2.0 (1.8, 2.2) 44 (33, 48) 127 11.7
New Mexico 3 1.9 (1.7, 2.2) 45 (32, 49) 53 14.3
Utah 3 1.9 (1.6, 2.1) 46 (35, 49) 51 11.3
Texas 3 1.9 (1.8, 1.9) 47 (43, 49) 532 12.7
Arizona 6 1.8 (1.7, 1.9) 48 (44, 49) 167 10.1
Hawaii 3 1.7 (1.4, 2.0) 49 (39, 49) 33 12.4
Puerto Rico 6 0.8 (0.7, 0.9) N/A 35 7.9
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 04/15/2024 1:04 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top